Le Lézard
Classified in: Health
Subjects: TDS, TRI, FVT

AnaBios to Announce Clinical Candidates for Chronic Pain at IASP World Congress on Pain


SAN DIEGO, Aug. 28, 2018 /PRNewswire/ -- AnaBios, the leader in translational pain research, will present its clinical candidates for the treatment of chronic pain at the 17th IASP World Congress on Pain on September 12 in Boston, Mass. The molecules?part of AnaBios' advanced internal drug discovery program?have a novel selectivity profile and properties, targeting ion channels highly expressed in pathological states associated with pain.

"We are very encouraged by the results obtained thus far from these novel compounds and believe they present a significant opportunity for developing non-opioid therapeutics to treat chronic pain," said Dr. Andre Ghetti, Chief Executive Officer of AnaBios. "One of the company's top priorities is to advance these molecules to human clinical studies."

AnaBios employs innovative, proprietary technology that enables the screening and optimization of novel compounds directly in human tissues. In addition to its proprietary programs, AnaBios leverages this unique platform, as well as decades of extensive biopharma expertise, to help support both academia and pharmaceutical drug discovery.

AnaBios' team of executives, including Chief Commercial Officer Dr. Chris Mathes and Dr. Paul E. Miller, co-founder and Chief of Corporate Development, will be at booth 420 during the IASP World Congress on Pain to discuss our pain research and validated human tissue offerings. To arrange a meeting, please contact us at [email protected].

About AnaBios
Located in San Diego, California, AnaBios aims to establish the safety and efficacy of novel compounds through its advanced, human-focused translational technologies. AnaBios primarily focuses on areas of high, unmet medical need, including cardiac disease, pain and itch. In addition to working with Fortune 500 biotech companies, CROs and academia, AnaBios drives an internal drug discovery platform via in-licensed programs from partners in the pharmaceutical industry. For more information about AnaBios, visit http://www.anabios.com.

 

SOURCE AnaBios


These press releases may also interest you

at 14:38
FDA Roundup: April 26, 2024
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA published the FDA Voices: "A Milestone in Facilitating the Development of Safe and Effective Biosimilars," by Sarah Yim,...

at 14:32
Curve Health and MindCare Forge Strategic Partnership to Elevate Behavioral Health Services in Skilled Nursing Facilities
Curve Health, a trailblazer in innovative healthcare solutions, is proud to announce a strategic partnership with MindCare, a leading provider of behavioral health services, with a focus on enhancing care delivery within Skilled Nursing Facilities...

at 14:05
YC-Backed Yoneda Labs Raises $4 Million Seed Led by Khosla Ventures to Build Foundation Model for Chemists
Yoneda Labs, the Y Combinator startup building a foundation model for chemists working in drug discovery, today announced it has raised $4 million in seed capital from Khosla Ventures, 500 Emerging Europe, 468 Capital, Fellows Fund, and Y Combinator....

at 14:00
People USA, in partnership with The Office of Mental Health, provides supportive housing for individuals re-entering the community from incarceration
People USA, funded by and in partnership with the New York State Office of Mental Health (OMH), is set to open 20 new scattered site housing units that will support individuals re-entering the community from New...

at 13:45
Harbor Point at Centerville Assisted Living Community Named One of the Country's Best by U.S. News & World Report for Third Straight Year
Harbor Point at Centerville, a Benchmark Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Massachusetts and the entire U.S. for the third straight year. In U.S. News & World Report's third annual...

at 13:45
Crescent Point at Niantic Assisted Living Community Named One of the Country's Best by U.S. News & World Report for Third Straight Year
Crescent Point at Niantic, a Benchmark assisted living and Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Connecticut and the entire U.S. for the third straight year. In U.S. News & World...

More news about Health...


News published on and distributed by: